Searched for
AUROBINDO PHARMA RESULTS
Midcap rally hides a deeper split: Every second stock down but index up 11% in 1 year. Are investors walking on thin ice?The Nifty Midcap 150 has gained around 11% over the past year, outperforming the Nifty’s 6% decline. However, the gains have been uneven, w...- Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDAAurobindo Pharma's US facility received a Voluntary Action Indicated classification. The US FDA closed its inspection of the Raleigh manufa...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Ahead of Market: 10 things that will decide D-Street action on MondayIndian benchmark indices closed lower on Friday as closing auction sessions caused divergence between Sensex and Nifty. While Sensex fell 4...
- Q1 earnings this week: SBI, Trent, Nykaa among 573 companies set to announce June quarter resultsThis week, 573 companies will announce their June quarter results, featuring prominent firms. Bharti Airtel and Nykaa are among those repor...
- Aurobindo Pharma shares jump 2% even as Q4 profit dips marginally to Rs 903 crAurobindo Pharma shares: Aurobindo Pharma reported a marginal 0.4% YoY dip in Q4FY25 PAT to Rs 903 crore, even as revenue rose 10.6% to Rs ...
- Aurobindo Pharma Q3 net profit drops 10% to Rs 846 croreAurobindo Pharma reported a 10% YoY decline in net profit to Rs 846 crore for Q3FY25, mainly due to a decrease in US sales. However, the co...
- Aurobindo Pharma Q2 net profit rises 8.6% to Rs 817 crore in Q2FY25Aurobindo Pharma witnessed an 8.6% YoY increase in net profit, reaching Rs 817 crore in Q2 FY25, driven by robust sales in Europe and growt...
- Aurobindo Pharma Q1 results: Net profit jumps 61% at Rs 919 croreRevenue from operations increased to Rs 7,567 crore in the June quarter as against Rs 6,851 crore in the year-ago period, the drug maker sa...
- Aurobindo Pharma Q2 Results: Net profit soars 84% to Rs 752 crore on strong overseas demandAurobindo Pharma on Thursday reported 84% year-on-year (YoY) rise in net profit to Rs 752 crore in the second quarter ended September 2023,...
- Aurobindo Pharma Q1 profit up 10 pc at Rs 571 crWith the product pipeline continuing to advance, and execution of growth drivers proceeding as planned, the company is confident that its f...
- Aurobindo Pharma Q1 Results: Profit down 32% YoY to Rs 520.5 croreThe company's focus on the development of specialty products pipeline will establish new avenues to grow the business in future and along w...
- Aurobindo Pharma Q3 Results: Net profit dips 22% to Rs 604 crRevenue from operations declined by 1 per cent to Rs 6,002.2 crore as against Rs 6,064.8 crore in the same period of last financial year, A...
- Aurobindo Pharma Q2 results: Net profit drops 2.1% YoY to Rs 697 croreRevenues declined 2.1 per cent to Rs 5942 crore in Q2FY22 compared to the previous year's Rs 6069 crore.
- Aurobindo Pharma Q1 net profit declines 2% to Rs 770 crConsolidated total revenue from operations of the company stood at Rs 5,701.98 crore for the quarter under consideration. It was Rs 5,924.7...
- Aurobindo Pharma Q4 results: Co reports net profit at Rs 801 croreFor the fiscal ended March this year, the company posted a net profit of Rs 5,333.83 crore. It was Rs 2,843.67 crore in the preceding fisca...
- Aurobindo Pharma Q3 profit inches lower to Rs 705 croreFormulation revenue for the quarter posted a growth of 17.4 per cent YoY to Rs 5,104.9 crore and accounted for 86.6 per cent of total reven...
- Aurobindo Pharma's subsidiary recalls epilepsy drug in USUS-based unit of drug firm Aurobindo Pharma is voluntarily recalling a lot Gabapentin capsules, an anti-epilepsy drug, in the American mark...
- Aurobindo Pharma posts net profit of Rs 393.40 crore in Q1Aurobindo Pharma today reported a consolidated net profit of Rs 393.40 cr in the first quarter ended June 30, 2014 on good performance of U...
- Aurobindo Pharma posts net loss of Rs 122.80 cr in Q1The company had reported a net profit of Rs 51.50 crore for the same period previous fiscal, Aurobindo Pharma said in a statement.
Load More
